For example, prostate carcinoma-secreted IL-6 can increase the expression of the cancer-associated fibroblast marker FAP, activating human prostate fibroblasts and enhancing the invasive ability of prostate cancer [28]. This evidence concerns the gene FAP and prostate carcinoma.